PubMed Health⌕ Search

Biomedical subjects

L Cloarec

Publications and source records attributed to L Cloarec.

At least 19 recordsLinked to original sources
PubMed1996

Arterial distensibility and circadian blood pressure variability.

OBJECTIVE: To analyse the relationships between arterial distensibility and blood pressure level and its circadian variability assessed by non-invasive ambulatory blood pressure monitoring. DESIGN: One hundred and six patients (69 men, 37 women; aged 20-72 years) without any cardiovascular complication or treatment underwent 24 h ambulatory blood pressure monitoring. Aortic distensibility was evaluated by carotid-femoral artery pulse-wave velocity measurements performed with a validated automatic device (Complior). RESULTS: The pulse-wave velocity correlated significantly with age (P < 0.001), systolic blood pressure (P < 0.01) and heart rate (P < 0.05). Subjects with higher pulse-wave velocities (above the median value) had higher ambulatory blood pressure and heart rate values, mainly during night-time, and present a smaller nocturnal fall both in systolic and in diastolic blood pressure than do those with lower pulse-wave velocities (below the median). The pulse-wave velocity was revealed to be an independent predictor of the nocturnal fall in systolic blood pressure (multiple r = 0.272, P < 0.02) whereas age and, to a lesser extent, mean 24 h diastolic blood pressure were independent predictors of the nocturnal fall in diastolic blood pressure (multiple r = 0.387, P < 0.001). CONCLUSION: Reductions in arterial distensibility are associated with increased blood pressure and heart rate levels whereas perturbations of the circadian blood pressure profile are associated with increased nocturnal values. The increased risk of end-organ damage and vascular events in the presence of higher nocturnal blood pressure values suggests that a study of arterial distensibility in the normal follow-up of hypertensive patients might be of benefit.

Journal Article↗
PubMed1996

Fortuitous diagnosis of the association of hemoglobin J-Broussais with beta + thalassemia.

The authors report a case, not described so far in literature, of an association of HbJ-Broussais [alpha (90 (PG2) lys-->asn beta 2] with beta + thalassemia in a young girl born of Italian father and Breton mother. This association is clinically silent. Biochemistry revealed, besides HbA, the presence of HbJ-Broussais in the proportion of 19.4% and HbA2 value of 3.9%. These percentages, slightly lower than expected, are explained. A familial study is presented.

Child↗
PubMed1995

Serum lipid, apolipoprotein and lipoparticle levels in the human fetus.

Blood collected from 62 fetuses aged 20-38 weeks of gestation was studied. The values of ten lipid parameters were determined: cholesterol (TC), triglycerides (TGs), apolipoprotein A1 (apo A1), apolipoprotein B (apo B), apolipoprotein E (apo E), total apolipoprotein CIII (apo CIII), apolipoprotein CIII present in particles containing apo B (apo CIII LpB) or not (apo CIII Lp non-B), lipoparticles A1 (LpA1), and lipoprotein a (Lp(a)). The results show that, except for apo E, all the studied parameters were present in lower concentrations than in adults and newborns, and that Lp(a) is not detectable at that stage in life.

Adolescent↗
PubMed1994

[Susceptibility of LDL to lipid peroxidation in non-insulin-dependent diabetes mellitus with or without macroangiopathy].

Since oxidized LDL may play a role in the genesis of atheroma, which is the primary complication of non-insulin-dependent diabetes mellitus (NIDDM), we investigated whether the LDL of diabetic patients were more prone to oxidation than those of healthy controls. We therefore studied the susceptibility of LDL to oxidation by phenylhydrazine (LDL-PO) in NIDDM patients with or without macroangiopathy, and in controls. Results showed that the LDL of patients with macroangiopathy (n = 50) were more susceptible to oxidation than those of both NIDDM patients without vascular complications (n = 50) and controls (n = 50). In diabetic patients, there was a positive correlation between LDL-PO and the following parameters: total cholesterol, triglycerides, LDL cholesterol, apolipoprotein B. In contrast, there was no correlation between LDL-PO and the parameters of glycemic control (fasting glucose, HbAlc). After analyzing the composition of LDL, it appeared that LDL-PO values in diabetic patients were positively correlated with those of all LDL constituents. The increase in LDL-PO observed in the group of NIDDM patients with macroangiopathy could be a consequence of an increase in the LDL triglyceride content in these patients.

Apolipoproteins B↗
PubMed1993

LDL sialic acid content in patients with coronary artery disease.

Low density lipoproteins (LDL) are considered to be the most atherogenic of lipoproteins. These LDL can be modified and oxidative modifications are now well known. In addition, other atherogenic modifications of LDL exist, such as desialylation. In the present study sialic acid content was determined in LDL preparations obtained from patients with coronary artery disease (CAD+) and compared with that of healthy subjects and patients without coronary heart disease (CAD-). The sialic acid concentration was found to be statistically lower (P < 0.05) in the LDL of CAD+ patients (11.6 +/- 2.7 micrograms/mg of protein) than in the LDL of controls (16.5 +/- 5.6 micrograms/mg of protein) or in the LDL of CAD- patients (15.3 +/- 3.8 micrograms/mg of protein). In subgroups of CAD+ patients divided according to the severity of the disease, no statistically significant difference was observed in LDL sialic acid content. This work confirms the presence of desialylated LDL in the sera of patients with atheroma.

Adult↗
PubMed1993

Plasma malondialdehyde in type 1 and type 2 diabetic patients.

Malondialdehyde, a marker of lipid peroxidation, was measured as thiobarbituric acid reactive substances (TBARS) in 117 diabetic patients and 53 controls. Patients were divided into groups and subgroups according to the type of diabetes (type 1 and type 2) and the existence or not of vascular complication (macro- or micro-angiopathy). Results showed that TBARS concentrations were significantly higher in type 1 (P < 0.0001) and type 2 (P < 0.001) diabetic patients than in the control group. The plasma TBARS concentrations in type 1 and type 2 diabetic patients did not differ significantly. Among the patients with vascular disease, type 2 diabetic patients with macroangiopathy had significantly higher TBARS concentrations than patients with no vascular complication (P < 0.05). Whichever the type of diabetes, there was no correlation between TBARS concentrations and glycaemic control: glycosylated haemoglobin, fasting blood glucose. This study confirmed the existence of lipid peroxidation disorders in diabetic patients.

Adult↗
PubMed1991

[Identification of a type 1 macrocreatine kinase].

A macrocreatine-kinase type 1 was identified by CK isoenzyme electrophoresis of a serum sample from a patient. Constituents of this enzyme complex were studied. The isoenzyme present in the macrocreatine-kinase was identified using immunoprecipitation with antibodies against the M subunit. Affinity chromatography then determined the type of the immunoglobulin bound to the CK isoenzyme. A protocol for studying macrocreatine-kinase type 1 compounds is proposed.

Chromatography, Affinity↗
PubMed1991

[Incidental diagnosis of homozygous alpha-zero thalassemia in a 21 week old fetus].

A fetus with signs of hydrops fetalis syndrome of unknown etiology, has been studied at 21 weeks. In fetal blood, total absence of HbA and HbF, presence of Hb Bart's, Hb Portland and HbH argued in favor of alpha zero-thalassemia syndrome. Because thalassemia syndromes were transmitted in a mendelian autosomal fashion, we studied the parents. Results suggest that the father was carrier of heterozygous alpha zero-thalassemia syndrome and the mother of hemoglobin H disease (and also heterozygous HbE). Neither of them was aware of being carrier of the disease but this results explain the fetal homozygous alpha zero-thalassemia.

Female↗
PubMed1990

Cutaneous interstitial fluid protein concentrations in the inflammatory syndrome: pharmacological consequences.

Concentrations of alpha 1 acid glycoprotein, albumin, transferrin, haptoglobin, immunoglobulins G, A, M and apolipoprotein B were measured in serum and suction blister fluid from a group of individuals presenting a biologically proven inflammatory syndrome, and from a control group. Protein values in suction blister fluid did not change from the 2nd to the 3rd h after the beginning of blister formation. The ratio of the concentration of proteins in blister fluid and serum did not differ significantly between the groups. However, a 25% decrease in blister fluid albumin and a 100% increase in blister fluid alpha 1 acid glycoprotein, recorded in the inflammatory group, were worth noting, since they possibly influence the tissular distribution of some protein-binding drugs. Finally, an inverse relationship was established between the blister fluid/serum concentration ratio and the respective molar mass of each protein.

Aged↗
PubMed1990

Blood chemistry of human fetuses in the second and third trimesters.

Six biochemical parameters and four enzyme activities were determined from the serum of 76 healthy and 56 pathological human fetuses between the 20th and 38th week of pregnancy. In the normal fetuses studied within that period, creatinine, immunoglobulin M, lactate dehydrogenase, and gamma-glutamyltransferase increased; haemoglobin F and glucose progressively decreased; and alkaline phosphatase was at a peak around the 26th week; cholesterol and triglycerides were always low. The same parameters were also measured in some of the pathological fetuses and compared with their normal counterparts.

Adult↗